NTRK-rearranged soft tissue sarcoma that originated from the head and neck with a robust response to the TRK inhibitor larotrectinib
Year: 2025
Type: article
Language: en
Topic: Sarcoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Nakano Kenji
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Oki Ryosuke
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Wang Xiaofei
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Nakao Takehiro
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Fukuda Naoki
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Urasaki Tetsuya
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Ono Makiko
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Tomomatsu Junichi
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Miura Yuji
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Division of Pathology , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan, Tokyo, 135-8550
raw_author_name: Sato Yukiko
raw_affiliation_strings: Division of Pathology , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan Tokyo 135-8550
Division of Pathology , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan, Tokyo, 135-8550
raw_author_name: Yamashita Kyoko
raw_affiliation_strings: Division of Pathology , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan Tokyo 135-8550
Division of Pathology , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan, Tokyo, 135-8550
raw_author_name: Takeuchi Kengo
raw_affiliation_strings: Division of Pathology , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan Tokyo 135-8550
Division of Genome Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 135-8550, Tokyo, Japan
raw_author_name: Hayashi Naomi
raw_affiliation_strings: Division of Genome Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 135-8550, Tokyo, Japan
raw_author_name: Fukada Ippei
raw_affiliation_strings: Division of Genome Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 135-8550, Tokyo, Japan
Division of Head and Neck , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan, Tokyo, 135-8550
raw_author_name: Mitani Hiroki
raw_affiliation_strings: Division of Head and Neck , Cancer Institute Hospital of Japanese Foundation for Cancer Research , Ariake, Japan Tokyo 135-8550
Division of Genome Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 135-8550, Tokyo, Japan
raw_author_name: Takahashi Shunji
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan
Division of Genome Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 135-8550, Tokyo, Japan
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550, Japan
raw_author_name: Kenji Nakano
raw_affiliation_strings: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, 135-8550 Japan